Valuation dashboard for Sanara MedTech Inc. (SMTI) with P/E N/A, P/B 38.51, EV/EBITDA 37.56 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities.
Analysis Summary
Sanara MedTech Inc. reported revenue of $103.1M in the most recent fiscal year, growing at a 5-year CAGR of 45.9%.
Trailing-twelve-month margins: gross margin 91.3%, operating margin 9.4%, net margin -29.2%.
At the current price of $35.10, SMTI has negative trailing earnings (P/E not meaningful) and an ROE of -473.55%. Market capitalisation stands at $323M.
Balance sheet quality for SMTI: current ratio of 1.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 38.51 |
| EV / EBITDA | 37.56 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $52.14 |
| vs Current Price | +48.5% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| SMTI | Sanara MedTech Inc. | $322M | 38.51 | -473.6% | |
| 0R29.L | Intuitive Surgical, Inc. | $131.0B | 71.41 | 11.44 | 16.0% |
| ISRG | Intuitive Surgical, Inc. | $130.4B | 43.34 | 7.48 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $50.3B | |||
| BDX | Becton, Dickinson and Company | $50.0B | 55.98 | 2.09 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 21.86 | 5.02 | 23.9% |
| 0KW4.L | ResMed Inc. | $32.5B | |||
| MDLN | Medline Inc. | $27.6B | 37.35 | 2.38 | 5.4% |
Price
| Price | $35.10 |
| Market Cap | $323M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -473.55% |
| Return on Invested Capital | 18.02% |
| Return on Assets | -46.30% |
| Gross Margin | 91.33% |
| Operating Margin | 9.36% |
| Net Margin | -29.15% |
Related companies: HITI · LFMD · NEO · OMI · SGHT · STXS · TBRG
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of SMTI: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks